$200 Million Raised to Engineer the Future of Military Working Dogs

The company Warhound has secured $200 million in funding to launch a project that combines genetic engineering with advanced robotics to create specialized working dogs. This new venture emerged from stealth on Thursday, supported by investors including Sequoia, 8VC, Corner Ventures, and In-Q-Tel, a firm backed by U.S. intelligence agencies. The investment values the startup at $1.2 billion. The primary goal is to produce animals capable of handling dangerous missions that are currently too risky for humans or too complex for existing machines.

The need for this innovation stems from a critical gap in the current supply chain. According to the company’s launch materials, more than 80 percent of the U.S. military’s working dogs originate from Europe. Furthermore, less than half of these imported animals are deemed fit for service. This reliance on foreign sources has created a dwindling supply of capable animals for defense and law enforcement. Warhound aims to change this dynamic by engineering dogs with specific traits suited for demanding operations, such as bomb detection and search missions.

The biological foundation of the project relies on technology from Colossal Biosciences. Ben Lamm of Colossal met with Palmer Luckey of Anduril at a conference about a year ago. Their discussions focused on improving the health and performance of military animals. Lamm researched breeding practices and found that many dogs fail training due to inherited issues like poor eyesight, cancer, hip dysplasia, or muscle atrophy. His team has collected cell lines from top-performing breeds, including the Belgian Malinois and German Shepherd, to use as a starting point for genetic editing.

Anduril will provide the technological hardware and software to support these new animals. This includes protection vests and goggles designed to enhance situational awareness for both the dogs and their handlers. Lamm described the concept as adding sensors to gear that send data back to operators, allowing for better coordination in the field. He emphasized that these enhancements are meant to protect the animals and their human partners, describing the technology as an addition on top of the dog rather than a change within it.

The production process involves cloning the engineered dogs using technology from Viagen, another company owned by Colossal. Lamm stated that the first batch of animals is ready for cloning and incubation. Births are expected in early next year, with the goal of having the dogs in service within two years. While the company has not yet set a price for the animals, it plans to sell them to the Department of Defense, military service groups, police forces, and other first responders. Lamm noted that the team has already briefed various government groups on the project.

Safety and ethical considerations are central to the rollout. Lamm explained that each dog will undergo standard military training and be managed by its purchasing agency. To ensure humane treatment, Warhound is working under the guidance of the American Humane Society to certify its training program. The society hopes that retired Warhound dogs will enter its Military Working Dog Reunification Program to find new homes. The American Humane Society stated that it looks forward to working with the team to ensure the animals are treated with scientific rigor and ethical care.